BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17888030)

  • 1. Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase-2 inhibitor, enoic acanthoic acid.
    Jung HJ; Shim JS; Suh YG; Kim YM; Ono M; Kwon HJ
    Cancer Sci; 2007 Dec; 98(12):1943-8. PubMed ID: 17888030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways.
    Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH
    Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.
    Yao M; Zhou W; Sangha S; Albert A; Chang AJ; Liu TC; Wolfe MM
    Clin Cancer Res; 2005 Feb; 11(4):1618-28. PubMed ID: 15746067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
    Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
    Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo.
    Martínez-Poveda B; Muñoz-Chápuli R; Rodríguez-Nieto S; Quintela JM; Fernández A; Medina MA; Quesada AR
    Mol Cancer Ther; 2007 Oct; 6(10):2675-85. PubMed ID: 17938261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
    Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
    Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts.
    Wu YL; Fu SL; Zhang YP; Qiao MM; Chen Y
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S289-92. PubMed ID: 16507395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis.
    Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH
    Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
    Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
    J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.
    Gualandris A; Rusnati M; Belleri M; Nelli EE; Bastaki M; Molinari-Tosatti MP; Bonardi F; Parolini S; Albini A; Morbidelli L; Ziche M; Corallini A; Possati L; Vacca A; Ribatti D; Presta M
    Cell Growth Differ; 1996 Feb; 7(2):147-60. PubMed ID: 8822198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.